BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 38652105)

  • 1. Non-apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages.
    Sun C; Zhan J; Li Y; Zhou C; Huang S; Zhu X; Huang K
    J Cell Mol Med; 2024 Apr; 28(8):e18348. PubMed ID: 38652105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
    Gao W; Wang X; Zhou Y; Wang X; Yu Y
    Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
    Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
    J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.
    Hsu SK; Li CY; Lin IL; Syue WJ; Chen YF; Cheng KC; Teng YN; Lin YH; Yen CH; Chiu CC
    Theranostics; 2021; 11(18):8813-8835. PubMed ID: 34522213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
    Woo Y; Lee HJ; Jung YM; Jung YJ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti-PD-1/PD-L1 cancer immunotherapy.
    Yu L; Huang K; Liao Y; Wang L; Sethi G; Ma Z
    Cell Prolif; 2024 Apr; ():e13644. PubMed ID: 38594879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
    Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
    Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
    J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy for non-small-cell lung cancer: New insights into regulated cell death combined with immunotherapy.
    Li S; Wang A; Wu Y; He S; Shuai W; Zhao M; Zhu Y; Hu X; Luo Y; Wang G
    Immunol Rev; 2024 Jan; 321(1):300-334. PubMed ID: 37688394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting novel regulated cell death:Ferroptosis, pyroptosis, and autophagy in sepsis-associated encephalopathy.
    Sun J; Fleishman JS; Liu X; Wang H; Huo L
    Biomed Pharmacother; 2024 May; 174():116453. PubMed ID: 38513593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential.
    Zhang Y; Zhou X
    Biomed Pharmacother; 2024 Jun; 175():116667. PubMed ID: 38703504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy.
    Giannone G; Ghisoni E; Genta S; Scotto G; Tuninetti V; Turinetto M; Valabrega G
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of ferroptosis in cancer: a matter of context?
    Catanzaro E; Demuynck R; Naessens F; Galluzzi L; Krysko DV
    Trends Cancer; 2024 May; 10(5):407-416. PubMed ID: 38368244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation.
    Ryter SW
    Cells; 2021 Feb; 10(3):. PubMed ID: 33671004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated cell death in cancer: from pathogenesis to treatment.
    Gong L; Huang D; Shi Y; Liang Z; Bu H
    Chin Med J (Engl); 2023 Mar; 136(6):653-665. PubMed ID: 35950752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Immunotherapies: From Efficacy to Resistance Mechanisms - Not Only Checkpoint Matters.
    Wang S; Xie K; Liu T
    Front Immunol; 2021; 12():690112. PubMed ID: 34367148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: insights into apoptosis, autophagy, ferroptosis, and pyroptosis.
    Chen C; Liu J; Lin X; Xiang A; Ye Q; Guo J; Rui T; Xu J; Hu S
    Cell Death Discov; 2024 Apr; 10(1):189. PubMed ID: 38649701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms.
    Li R; Wu Y; Li Y; Shuai W; Wang A; Zhu Y; Hu X; Xia Y; Ouyang L; Wang G
    Eur J Med Chem; 2024 Feb; 265():116040. PubMed ID: 38142509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated Cell Death in Endometriosis.
    Huang E; Wang X; Chen L
    Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting regulated cell death (RCD) with small-molecule compounds in cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death and necroptosis.
    Liu W; Jin W; Zhu S; Chen Y; Liu B
    Drug Discov Today; 2022 Feb; 27(2):612-625. PubMed ID: 34718209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.